[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Royalty Pharma Plc Cl A (RPRX)

Royalty Pharma Plc Cl A (RPRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 33,703,444
  • Shares Outstanding, K 575,832
  • Annual Sales, $ 2,378 M
  • Annual Income, $ 770,950 K
  • EBIT $ 1,588 M
  • EBITDA $ 1,621 M
  • 60-Month Beta 0.43
  • Price/Sales 13.64
  • Price/Cash Flow 11.79
  • Price/Book 3.27

Options Overview Details

View History
  • Implied Volatility 36.73% (+0.60%)
  • Historical Volatility 27.66%
  • IV Percentile 48%
  • IV Rank 26.83%
  • IV High 75.80% on 01/14/26
  • IV Low 22.41% on 06/10/26
  • Expected Move (DTE 34) 2.19 (3.77%)
  • Put/Call Vol Ratio 0.23
  • Today's Volume 808
  • Volume Avg (30-Day) 525
  • Put/Call OI Ratio 0.17
  • Today's Open Interest 12,462
  • Open Int (30-Day) 11,353
  • Expected Range 55.99 to 60.37

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 8 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $1.27
  • Number of Estimates 3
  • High Estimate $1.30
  • Low Estimate $1.26
  • Prior Year $1.14
  • Growth Rate Est. (year over year) +11.40%

Price Performance

See More
Period Period Low Period High Performance
1-Month
51.15 +13.74%
on 06/18/26
59.44 -2.12%
on 07/17/26
+4.48 (+8.34%)
since 06/17/26
3-Month
48.88 +19.03%
on 04/21/26
59.44 -2.12%
on 07/17/26
+8.18 (+16.36%)
since 04/17/26
52-Week
34.08 +70.71%
on 09/08/25
59.44 -2.12%
on 07/17/26
+22.71 (+64.03%)
since 07/17/25

Most Recent Stories

More News
Royalty Pharma declares third quarter 2026 dividend

NEW YORK, July 17, 2026 (GLOBE NEWSWIRE) -- The board of directors of Royalty Pharma plc (Nasdaq: RPRX) has approved the payment of a dividend for the third quarter of 2026 of $0.235 per Class A ordinary...

RPRX : 58.18 (-0.60%)
Royalty Pharma to announce second quarter 2026 financial results on August 5, 2026

NEW YORK, July 15, 2026 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced that it will report its second quarter 2026 financial results on Wednesday, August 5, 2026 before the U.S....

RPRX : 58.18 (-0.60%)
Branded Pharmaceuticals Stocks Q1 Recap: Benchmarking Royalty Pharma (NASDAQ:RPRX)

Branded Pharmaceuticals Stocks Q1 Recap: Benchmarking Royalty Pharma (NASDAQ:RPRX)

RPRX : 58.18 (-0.60%)
Branded Pharmaceuticals Stocks Q1 Recap: Benchmarking Royalty Pharma (NASDAQ:RPRX)

Branded Pharmaceuticals Stocks Q1 Recap: Benchmarking Royalty Pharma (NASDAQ:RPRX)

RPRX : 58.18 (-0.60%)
3 Unpopular Stocks We’re Skeptical Of

3 Unpopular Stocks We’re Skeptical Of

RPRX : 58.18 (-0.60%)
BAX : 22.61 (-3.17%)
KFY : 78.61 (-0.33%)
Royalty Pharma (RPRX): Buy, Sell, or Hold Post Q1 Earnings?

Royalty Pharma (RPRX): Buy, Sell, or Hold Post Q1 Earnings?

RPRX : 58.18 (-0.60%)
Royalty Pharma to present at the Goldman Sachs 47th Annual Global Healthcare Conference

NEW YORK, June 04, 2026 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced that it will participate in a fireside chat at the Goldman Sachs 47th Annual Global Healthcare Conference...

RPRX : 58.18 (-0.60%)
3 Mid-Cap Stocks We Steer Clear Of

3 Mid-Cap Stocks We Steer Clear Of

RPRX : 58.18 (-0.60%)
GDDY : 94.35 (-1.93%)
AMKR : 62.94 (-0.13%)
Royalty Pharma’s Q1 Earnings Call: Our Top 5 Analyst Questions

Royalty Pharma’s Q1 Earnings Call: Our Top 5 Analyst Questions

RPRX : 58.18 (-0.60%)
Royalty Pharma to present at upcoming investor conferences

NEW YORK, May 07, 2026 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced that it will participate in the following upcoming investor conferences during the month of May: BofA...

RPRX : 58.18 (-0.60%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Royalty Pharma plc is a funder of biopharmaceutical industry. The compnay's portfolio includes royalties on commercial products, including AbbVie and J&J's Imbruvica, Astellas and Pfizer's Xtandi, Biogen's Tysabri, Gilead's HIV franchise, Merck's Januvia, Novartis' Promacta and Vertex's Kalydeco, Symdeko...

See More

Key Turning Points

3rd Resistance Point 60.37
2nd Resistance Point 59.90
1st Resistance Point 59.04
Last Price 58.18
1st Support Level 57.72
2nd Support Level 57.25
3rd Support Level 56.39

See More

52-Week High 59.44
Last Price 58.18
Fibonacci 61.8% 49.75
Fibonacci 50% 46.76
Fibonacci 38.2% 43.77
52-Week Low 34.08

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.